AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Hollis-Eden Presents Promising HIV Study Results at World AIDS Conference In South Africa.
Investigational Drug HE2000 Targets Immune System
SAN DIEGO, July 11 /PRNewswire/ --
Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) today announced the presentation of clinical data from HIV-infected patients being treated with the Company's investigational drug candidate HE2000 in a Phase I/II clinical trial in South Africa. The data were presented in a poster session at the World AIDS Conference being held in Durban, South Africa. At the presentation, investigators are discussing data from the study indicating that statistically significant increases in key immune system cells were seen across the 37 patients reported on from the study. These immune system cells are recognized as being important in containing HIV and fighting opportunistic infections. In addition, HE2000 has been generally well tolerated, with injection site pain and irritation being the only drug-related serious adverse event being reported.
The Phase I/II clinical trial in South Africa is a dose escalation study evaluating the effect of HE2000 in three dosing groups (50 mg, 100 mg or 200 mg). Patients initially receive a single injection followed one to two weeks later by a daily injection for five consecutive days. After a four to six week observation period, patients demonstrating benefit are allowed to receive…
- HIV handicaps itself to escape immune system pressure.
- Newspaper article from: AIDS Vaccine Week April 27, 2009 700+ words
...genes that help the immune system recognize and fight...people in Zambia and South Africa with one form of the HLA gene that helps the immune system control HIV, called...thrive because the immune system can't fight against...
- Hollis-Eden Presents HIV Study Results on Promising Investigational Drug...
- Press release article from: PR Newswire April 10, 2000 700+ words
...Embassy Drive Medical Center of South Africa and an investigator in the...for infectious disease and immune system disorders that target the...this approach will lead to immune system responses to infectious diseases...attractive safety profile. In the immune system ...
- AIDS vaccine trials begin in South Africa, Switzerland.
- Newspaper article from: Biotech Week December 10, 2003 700+ words
...currently is in trials. In South Africa, HIVA.MVA is the second...AIDS vaccine research in South Africa is coordinated by the South...vaccine to stimulate the human immune system to fight HIV/AIDS. In South Africa, the first preventive AIDS...
- IAVI Begins AIDS Vaccine Trials in South Africa, Switzerland.
- Press release article from: PR Newswire November 12, 2003 700+ words
...currently is in trials. In South Africa, HIVA.MVA is the second...AIDS vaccine research in South Africa is coordinated by the South...vaccine to stimulate the human immune system to fight HIV/AIDS. In South Africa, the first preventive AIDS...
- Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune...
- Press release article from: PR Newswire November 30, 2007 700+ words
...research and treatment of children's immune system disorders and infectious diseases...hospital. In 2006 she spent six weeks in South Africa on a medical mission sponsored by Bristol...One of the many things I learned in South Africa is that children and families who are...
- Cancer Advances Acquires the Intellectual Property for a Suite of Products that...
- Press release article from: PR Newswire February 2, 2009 700+ words
...intellectual property for a suite of products that enhance the immune system for application in three gastrointestinal cancers. Cancer...the United States, Europe, Canada, Israel, India, and South Africa, Cato Research's services range from design and management...
- SOUTH AFRICA TO BEGIN AIDS VACCINE TRIALS.
- News wire article from: Asia Africa Intelligence Wire August 25, 2003 700+ words
...South Africa, said: "South Africa's research community...than one at a time, South Africa will help reduce the...candidates to stimulate the immune system. By conducting the...trials side by side, South Africa will help gather data...
- Hollis-Eden Begins Phase I/II Clinical Trials in South Africa With...
- Press release article from: PR Newswire May 6, 1999 700+ words
...treatment of HIV/AIDS in South Africa with US clinical trials...regulatory team has been in South Africa for the past week preparing...stimulation of the immune system and what role that...HIV. The trials in South Africa will evaluate HE2000...
- Hollis-Eden Pharmaceuticals to Present Update on HE2000 At World AIDS...
- Press release article from: PR Newswire June 20, 2000 700+ words
...Conference in Durban, South Africa, July 9-14, 2000...to boost a number of immune system parameters in HIV patients...Virology in Johannesburg, South Africa, is the lead author...the activation of key immune system cells that are believed...
- Council approves first HIV vaccine trial in South Africa.
- News wire article from: Asia Africa Intelligence Wire June 19, 2003 700+ words
...vaccine trial in South Africa. This is a Phase...the safety and immune system responses induced...United States and South Africa. The vaccine...vaccine to the immune system. This is the...trial sites in South Africa - the Perinatal...
Source: HighBeam Research, Hollis-Eden Presents Promising HIV Study Results at World AIDS...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
